Recce Pharmaceutical...
ASX:RCE
$ 0,50
+ $0,02 (4,17%)
0,50 $
+$0,02 (4,17%)
End-of-day quote: 04/13/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$-0,10
Earnings Per Share
$0,02
Revenue Per Share
0,00%
Gross Margin %
$0,14 B
Market Cap
$0,01 B
Long-Term Debt
Earnings Per Share
$-0,10
Revenue Per Share
$0,02
Gross Margin %
0,00%
Market Cap
$0,14 B
Long-Term Debt
$0,01 B

Financials

Year Year 2026 2025 2024 2023 2014 2013 2012
EPS Earnings Per Share $-0,09 $-0,10 $-0,08 $0,00 $0,00 $0,00
Earnings Earnings $-25,95M $-23,16M $-15,75M $0,00M $0,00M $0,00M
RPS Revenue Per Share $0,00 $0,03 $0,02 $0,02 N/A N/A N/A
Revenue Revenue $0,00M $7,70M $5,24M $4,31M $0,00M $0,00M $0,00M
OCF Operating Cash Flow $0,00M $-20,44M $-13,01M $0,00M $0,00M $0,00M $0,00M
FCF Free Cash Flow $0,00M $-20,47M $-13,15M $-12,73M $0,00M $0,00M $0,00M
OM Operating Margin 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00%
GM % Gross Margin % 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00%
FCFS Free Cash Flow Per Share $0,00 $0,00 $0,00 $0,00 $0,00 $0,00 $0,00
LT Debt Long-Term Debt N/A $8,60M $8,60M N/A N/A N/A N/A
Sha. Stocks 288,37M 288,37M 231,61M 196,83M 0M 0M 0M
×